Inhibition of the oxidoreductase enzyme DprE1 of \(Mycobacterium\) \(tuberculosis\) by two small compounds DprE1 is an essential oxidoreductase enzyme found in the pathogen \(Mycobacterium\) \(tuberculosis\), the causative agent of the disease tuberculosis. The recent emergence of multi-drug (MDR-) and extensively-drug resistant (XDR-TB) strains of TB has highlighted the need for new drugs to complement an outdated treatment regimen. This project details the purification of DprE1 and the efforts made to characterize its interaction with two small compounds thought to be inhibitors, 1326 and 1328. The K\(_d\) value of each compound was determined and the design of two plasmids for the overexpression of \(Pseudomonas\) \(aeruginosa\) and ...
The development and spread of Mycobacterium tuberculosis multi-drug resistant strains still represen...
Current therapies for treatment of mycobacterial infections are adequate when diagnosis and patholog...
The rapid emergence of drug-resistant Mycobacterium tuberculosis (Mtb) coupled to the high incidence...
An estimated 1.67 million people died of tuberculosis (TB) in 2016 and it is a threat to human life ...
The re-emergence of tuberculosis in recent years led the World Health Organization (WHO) to launch t...
DprE2 is an essential enzyme for \(Mycobacterium\) \(tuberculosis\) (M.tb); it is involved in the b...
Decaprenylphosphoryl-β-d-ribose 2'-epimerase (DprE1) is a critical flavoenzyme in Mycobacterium tube...
Mycobacterium tuberculosis causes tuberculosis (TB), which is a common but life‐debilitating disease...
Tuberculosis, caused by the pathogenic bacteria Mycobacterium tuberculosis, is one of the most wides...
The increase in the drug-resistant strains of Mycobacterium tuberculosis has led researchers to new ...
Tuberculosis (TB) is the leading cause of infectious disease mortality in the world by a single bact...
Tuberculosis is still a leading cause of death in developing countries and a resurgent disease in de...
We have targeted the Mycobacterium tuberculosis decaprenylphosphoryl-β-d-ribose oxidase (Mt-DprE1) f...
The enzyme DXS catalyzes the first, rate-limiting step of the 2-C-methyl-d-erythritol-4-phosphate (M...
Decaprenylphosphoryl-β-d-ribose 2′-epimerase (DprE1), a vital enzyme for cell wall synthesis, plays ...
The development and spread of Mycobacterium tuberculosis multi-drug resistant strains still represen...
Current therapies for treatment of mycobacterial infections are adequate when diagnosis and patholog...
The rapid emergence of drug-resistant Mycobacterium tuberculosis (Mtb) coupled to the high incidence...
An estimated 1.67 million people died of tuberculosis (TB) in 2016 and it is a threat to human life ...
The re-emergence of tuberculosis in recent years led the World Health Organization (WHO) to launch t...
DprE2 is an essential enzyme for \(Mycobacterium\) \(tuberculosis\) (M.tb); it is involved in the b...
Decaprenylphosphoryl-β-d-ribose 2'-epimerase (DprE1) is a critical flavoenzyme in Mycobacterium tube...
Mycobacterium tuberculosis causes tuberculosis (TB), which is a common but life‐debilitating disease...
Tuberculosis, caused by the pathogenic bacteria Mycobacterium tuberculosis, is one of the most wides...
The increase in the drug-resistant strains of Mycobacterium tuberculosis has led researchers to new ...
Tuberculosis (TB) is the leading cause of infectious disease mortality in the world by a single bact...
Tuberculosis is still a leading cause of death in developing countries and a resurgent disease in de...
We have targeted the Mycobacterium tuberculosis decaprenylphosphoryl-β-d-ribose oxidase (Mt-DprE1) f...
The enzyme DXS catalyzes the first, rate-limiting step of the 2-C-methyl-d-erythritol-4-phosphate (M...
Decaprenylphosphoryl-β-d-ribose 2′-epimerase (DprE1), a vital enzyme for cell wall synthesis, plays ...
The development and spread of Mycobacterium tuberculosis multi-drug resistant strains still represen...
Current therapies for treatment of mycobacterial infections are adequate when diagnosis and patholog...
The rapid emergence of drug-resistant Mycobacterium tuberculosis (Mtb) coupled to the high incidence...